
### [Orphanet:229720](http://www.orpha.net/ORDO/Orphanet_229720)
**Label:** Syndromic agammaglobulinemia

**Subclasses:** [Orphanet:83617](http://www.orpha.net/ORDO/Orphanet_83617) (Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome), [Orphanet:632](http://www.orpha.net/ORDO/Orphanet_632) (Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia), 

**Corr. equiv. classes:** [OMIM:610483](http://purl.obolibrary.org/obo/OMIM_610483), [Orphanet:83617](http://www.orpha.net/ORDO/Orphanet_83617), [OMIM:307200](http://purl.obolibrary.org/obo/OMIM_307200), [Orphanet:632](http://www.orpha.net/ORDO/Orphanet_632), 

**Class expressions from DL-Learner:**

- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0040075](http://purl.obolibrary.org/obo/HP_0040075) (Hypopituitarism) 62.50%
- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0012503](http://purl.obolibrary.org/obo/HP_0012503) (Abnormality of the pituitary gland) 62.50%
- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 62.50%
- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology) 62.50%
- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0011747](http://purl.obolibrary.org/obo/HP_0011747) (Abnormality of the anterior pituitary) 62.50%
- [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 62.50%
- [HP:0003139](http://purl.obolibrary.org/obo/HP_0003139) (Panhypogammaglobulinemia) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0002750](http://purl.obolibrary.org/obo/HP_0002750) (Delayed skeletal maturation) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0001510](http://purl.obolibrary.org/obo/HP_0001510) (Growth delay) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0000927](http://purl.obolibrary.org/obo/HP_0000927) (Abnormality of skeletal maturation) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0000864](http://purl.obolibrary.org/obo/HP_0000864) (Abnormality of the hypothalamus-pituitary axis) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0000830](http://purl.obolibrary.org/obo/HP_0000830) (Anterior hypopituitarism) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%
- [HP:0000824](http://purl.obolibrary.org/obo/HP_0000824) (Growth hormone deficiency) and [HP:0003729](http://purl.obolibrary.org/obo/HP_0003729) (Enteroviral dermatomyositis syndrome) 62.50%


